<VariationArchive VariationID="6553" VariationName="NM_003722.5(TP63):c.1833_1843dup (p.His615fs)" VariationType="Duplication" Accession="VCV000006553" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2018-10-18" MostRecentSubmission="2018-10-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21592" VariationID="6553">
      <GeneList>
        <Gene Symbol="TP63" FullName="tumor protein p63" GeneID="8626" HGNC_ID="HGNC:15979" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189596746" stop="189897276" display_start="189596746" display_stop="189897276" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189349215" stop="189615067" display_start="189349215" display_stop="189615067" Strand="+" />
          </Location>
          <OMIM>603273</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003722.5(TP63):c.1833_1843dup (p.His615fs)</Name>
      <CanonicalSPDI>NC_000003.12:189894286:TTCTCCTCCCCTTCTC:TTCTCCTCCCCTTCTCCTCCCCTTCTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189894286" stop="189894287" display_start="189894286" display_stop="189894287" variantLength="11" positionVCF="189894286" referenceAlleleVCF="A" alternateAlleleVCF="ATTCTCCTCCCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189612075" stop="189612076" display_start="189612075" display_stop="189612076" variantLength="11" positionVCF="189612075" referenceAlleleVCF="A" alternateAlleleVCF="ATTCTCCTCCCC" />
      </Location>
      <ProteinChange>H436fs</ProteinChange>
      <ProteinChange>H521fs</ProteinChange>
      <ProteinChange>H611fs</ProteinChange>
      <ProteinChange>H613fs</ProteinChange>
      <ProteinChange>H615fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.189612081_189612091dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.189612081_189612091dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.189894292_189894302dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.189894292_189894302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007550.3" sequenceAccession="NG_007550" sequenceVersion="3" change="g.302547_302557dup">
            <Expression>NG_007550.3:g.302547_302557dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114978.2" sequenceAccession="NM_001114978" sequenceVersion="2" change="c.*71_*81dup">
            <Expression>NM_001114978.2:c.*71_*81dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114980.2" sequenceAccession="NM_001114980" sequenceVersion="2" change="c.1551_1561dup" MANEPlusClinical="true">
            <Expression>NM_001114980.2:c.1551_1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108452.1" sequenceAccession="NP_001108452" sequenceVersion="1" change="p.His521fs">
            <Expression>NP_001108452.1:p.His521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114981.2" sequenceAccession="NM_001114981" sequenceVersion="2" change="c.*71_*81dup">
            <Expression>NM_001114981.2:c.*71_*81dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329144.2" sequenceAccession="NM_001329144" sequenceVersion="2" change="c.*61_*71dup">
            <Expression>NM_001329144.2:c.*61_*71dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329145.2" sequenceAccession="NM_001329145" sequenceVersion="2" change="c.*61_*71dup">
            <Expression>NM_001329145.2:c.*61_*71dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329146.2" sequenceAccession="NM_001329146" sequenceVersion="2" change="c.1296_1306dup">
            <Expression>NM_001329146.2:c.1296_1306dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316075.1" sequenceAccession="NP_001316075" sequenceVersion="1" change="p.His436fs">
            <Expression>NP_001316075.1:p.His436fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329148.2" sequenceAccession="NM_001329148" sequenceVersion="2" change="c.1821_1831dup">
            <Expression>NM_001329148.2:c.1821_1831dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316077.1" sequenceAccession="NP_001316077" sequenceVersion="1" change="p.His611fs">
            <Expression>NP_001316077.1:p.His611fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329149.2" sequenceAccession="NM_001329149" sequenceVersion="2" change="c.*61_*71dup">
            <Expression>NM_001329149.2:c.*61_*71dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329150.2" sequenceAccession="NM_001329150" sequenceVersion="2" change="c.*61_*71dup">
            <Expression>NM_001329150.2:c.*61_*71dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329964.2" sequenceAccession="NM_001329964" sequenceVersion="2" change="c.1827_1837dup">
            <Expression>NM_001329964.2:c.1827_1837dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316893.1" sequenceAccession="NP_001316893" sequenceVersion="1" change="p.His613fs">
            <Expression>NP_001316893.1:p.His613fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003722.5" sequenceAccession="NM_003722" sequenceVersion="5" change="c.1833_1843dup" MANESelect="true">
            <Expression>NM_003722.5:c.1833_1843dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003713.3" sequenceAccession="NP_003713" sequenceVersion="3" change="p.His615fs">
            <Expression>NP_003713.3:p.His615fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_428" sequenceAccession="LRG_428">
            <Expression>LRG_428:g.302547_302557dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_428t1" sequenceAccession="LRG_428t1">
            <Expression>LRG_428t1:c.1833_1843dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_428p1" sequenceAccession="LRG_428p1" change="p.His615fs">
            <Expression>LRG_428p1:p.His615fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603273.0027" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 603273.0027 based on the location in current RefSeqs of the duplicated sequence reported in the text in OMIM.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003722.5(TP63):c.1833_1843dup (p.His615fs) AND Rapp-Hodgkin ectodermal dysplasia syndrome" Accession="RCV000006929" Version="13">
        <ClassifiedConditionList TraitSetID="1810">
          <ClassifiedCondition DB="MedGen" ID="C1785148">Rapp-Hodgkin ectodermal dysplasia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003722.5(TP63):c.1833_1843dup (p.His615fs) AND Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome" Accession="RCV001794436" Version="9">
        <ClassifiedConditionList TraitSetID="1811">
          <ClassifiedCondition DB="MedGen" ID="C0406709">Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-01-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2018-10-18" MostRecentSubmission="2018-10-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19239083</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1810" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3593" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rapp-Hodgkin syndrome</ElementValue>
                <XRef ID="MONDO:0007508" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rapp-Hodgkin ectodermal dysplasia syndrome</ElementValue>
                <XRef ID="Rapp-Hodgkin+syndrome/6153" DB="Genetic Alliance" />
                <XRef ID="7731005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectodermal dysplasia, anhidrotic, with cleft lip/palate</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RHS</ElementValue>
                <XRef Type="MIM" ID="129400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The TP63-related disorders comprise six overlapping phenotypes: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome). Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome. Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3). Limb-mammary syndrome. Split-hand/foot malformation type 4 (SHFM4). Isolated cleft lip/cleft palate (orofacial cleft 8). Individuals typically have varying combinations of ectodermal dysplasia (hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, hypoplastic breasts and/or nipples, and hypospadias. Findings associated with a single phenotype include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring, and alopecia, trismus, and excessive freckling.</Attribute>
                <XRef ID="NBK43797" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TP63-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5690" />
                <XRef ID="5690" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20556892</ID>
                <ID Source="BookShelf">NBK43797</ID>
              </Citation>
              <XRef ID="3022" DB="Orphanet" />
              <XRef ID="C1785148" DB="MedGen" />
              <XRef ID="MONDO:0007508" DB="MONDO" />
              <XRef Type="MIM" ID="129400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1811" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="410" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ankyloblepharon-ectodermal defects, cleft lip/palate</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hay-Wells syndrome of ectodermal dysplasia</ElementValue>
                <XRef ID="Hay-Wells+Syndrome/3251" DB="Genetic Alliance" />
                <XRef ID="55821006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEC syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hay-Wells syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome</ElementValue>
                <XRef ID="MONDO:0007124" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6571" />
                <XRef ID="6571" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The TP63-related disorders comprise six overlapping phenotypes: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome). Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome. Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3). Limb-mammary syndrome. Split-hand/foot malformation type 4 (SHFM4). Isolated cleft lip/cleft palate (orofacial cleft 8). Individuals typically have varying combinations of ectodermal dysplasia (hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, hypoplastic breasts and/or nipples, and hypospadias. Findings associated with a single phenotype include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring, and alopecia, trismus, and excessive freckling.</Attribute>
                <XRef ID="NBK43797" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TP63-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20556892</ID>
                <ID Source="BookShelf">NBK43797</ID>
              </Citation>
              <XRef ID="1071" DB="Orphanet" />
              <XRef ID="C0406709" DB="MedGen" />
              <XRef ID="MONDO:0007124" DB="MONDO" />
              <XRef Type="MIM" ID="106260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27126" SubmissionDate="2018-10-14" DateLastUpdated="2018-10-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603273.0027_ANKYLOBLEPHARON-ECTODERMAL DEFECTS, CLEFT LIP/PALATE" title="TP63, 11-BP DUP, NT1716_ANKYLOBLEPHARON-ECTODERMAL DEFECTS, CLEFT LIP/PALATE" />
        <ClinVarAccession Accession="SCV000027126" DateUpdated="2018-10-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old boy who displayed an overlapping phenotype with features of both ankyloblepharon-ectodermal defects-clefting syndrome (AEC; 106260) and Rapp-Hodgkin syndrome (RHS; 129400), Prontera et al. (2008) identified heterozygosity for an 11-bp duplication (1716dupCTCCCCTTCTC) in exon 14 of the TP63 gene, predicted to result in a protein that is 26 amino acids longer than wildtype. The mutation is located in the transcriptional inhibitory domain (TID) and is predicted to affect only the TP63-alpha isoforms. The patient was born with bilateral ankyloblepharon filiforme adnatum and submucous cleft palate and was diagnosed with AEC syndrome; however, he had only slight erythema of the scalp without infection or erosion or areas of eczematous skin. Upon reevaluation at age 11 years, he showed facial dysmorphism including high frontal hairline, hypoplastic alae nasi, pinched and narrow nose, midface hypoplasia with relative prognathism, and had hypohidrosis and syndactyly, features more suggestive of a diagnosis of RHS.</Attribute>
              <Citation>
                <ID Source="PubMed">19239083</ID>
              </Citation>
              <XRef DB="OMIM" ID="106260" Type="MIM" />
              <XRef DB="OMIM" ID="129400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP63" />
          </GeneList>
          <Name>TP63, 11-BP DUP, NT1716</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DUP, NT1716</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603273.0027" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ANKYLOBLEPHARON-ECTODERMAL DEFECTS, CLEFT LIP/PALATE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27125" SubmissionDate="2018-10-14" DateLastUpdated="2018-10-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603273.0027_RAPP-HODGKIN SYNDROME" title="TP63, 11-BP DUP, NT1716_RAPP-HODGKIN SYNDROME" />
        <ClinVarAccession Accession="SCV000027125" DateUpdated="2018-10-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old boy who displayed an overlapping phenotype with features of both ankyloblepharon-ectodermal defects-clefting syndrome (AEC; 106260) and Rapp-Hodgkin syndrome (RHS; 129400), Prontera et al. (2008) identified heterozygosity for an 11-bp duplication (1716dupCTCCCCTTCTC) in exon 14 of the TP63 gene, predicted to result in a protein that is 26 amino acids longer than wildtype. The mutation is located in the transcriptional inhibitory domain (TID) and is predicted to affect only the TP63-alpha isoforms. The patient was born with bilateral ankyloblepharon filiforme adnatum and submucous cleft palate and was diagnosed with AEC syndrome; however, he had only slight erythema of the scalp without infection or erosion or areas of eczematous skin. Upon reevaluation at age 11 years, he showed facial dysmorphism including high frontal hairline, hypoplastic alae nasi, pinched and narrow nose, midface hypoplasia with relative prognathism, and had hypohidrosis and syndactyly, features more suggestive of a diagnosis of RHS.</Attribute>
              <Citation>
                <ID Source="PubMed">19239083</ID>
              </Citation>
              <XRef DB="OMIM" ID="106260" Type="MIM" />
              <XRef DB="OMIM" ID="129400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP63" />
          </GeneList>
          <Name>TP63, 11-BP DUP, NT1716</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DUP, NT1716</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603273.0027" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RAPP-HODGKIN SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27125" TraitType="Disease" MappingType="Name" MappingValue="RAPP-HODGKIN SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1785148" Name="Rapp-Hodgkin ectodermal dysplasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27126" TraitType="Disease" MappingType="Name" MappingValue="ANKYLOBLEPHARON-ECTODERMAL DEFECTS, CLEFT LIP/PALATE" MappingRef="Alternate">
        <MedGen CUI="C0406709" Name="Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

